CELforPharma
The webinar explains EU joint clinical assessment and joint scientific consultation processes, relevant guidance and use of the HTA IT Platform. It is intended for medicinal-product developers and includes practical information about submitting early information for HTA.
Please accept {{cookieConsents}} cookies to view this content